#news #biotech Albireo CMO Horn is out the door 5 months after US, EU approvals of rare liver disease drug

Biotechnology, Pharma and Biopharma News – Research – Science – Lifescience ://Biotech-Biopharma-Pharma: Albireo CMO Horn is out the door 5 months after US, EU approvals of rare liver disease drug .Albireo CMO Horn is out the door 5 months after US, EU approvals of rare liver disease drug
klahucik
Thu, 12/09/2021 – 14:02

from FierceBiotech: Biotech https://ift.tt/3pLbTvw